$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Oral Antihyperglycemic Medication Nonadherence and Subsequent Hospitalization Among Individuals With Type 2 Diabetes 원문보기

Diabetes care, v.27 no.9, 2004년, pp.2149 - 2153  

Lau, Denys T. (Pfizer Research Fellowship Program, Department of Health Management and Policy, The University of Michigan School of Public Health, Ann Arbor, Michigan) ,  Nau, David P. (Department of Social and Administrative Sciences, The University of Michigan College of Pharmacy, Ann Arbor, Michigan)

Abstract AI-Helper 아이콘AI-Helper

OBJECTIVE-This study examines the association between oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes.RESEARCH DESIGN AND METHODS-Using administrative claims data (2000-2001) from a managed care organization in the Midwestern U.S.,...

참고문헌 (33)

  1. 10.2337/diacare.25.6.1015 Schectman JM, Nadkarni MM, Voss JD: The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 25:1015-1021, 2002 

  2. 10.1056/NEJM199309303291401 Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993 

  3. 10.1016/S0140-6736(98)07019-6 UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998 

  4. 10.1016/S0149-2918(01)80110-7 Dailey G, Kim MS, Lian JF: Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a Medicaid patient population with type 2 diabetes mellitus. Clin Ther 23:1311-1320, 2001 

  5. 10.1046/j.1464-5491.2002.00689.x Donnan PT, MacDonald TM, Morris AD: Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med 19:279-284, 2002 

  6. 10.1016/S1262-3636(07)70011-3 Guillausseau PJ: Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes: a survey in general practice. Diabetes Metab 29:79-81, 2003 

  7. 10.18553/jmcp.1999.5.4.336 Hsaio LD, Salmon JW: Predicting adherence to prescription medication purchase among HMO enrollees with diabetes. J Manag Care Pharm 5:336-341, 1991 

  8. Nau DP, Garber MC, Herman WH: The intensification of drug therapy for diabetes and its complications: evidence from 2 HMOs. Am J Manag Care 10:118-123, 2004 

  9. 10.1176/ajp.152.6.856 Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL Jr, Davis JM, Lewis DA: Predicting the “revolving door” phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatr 152:856-861, 1995 

  10. 10.1097/00005650-200208000-00002 Valenstein M, Copeland LA, Blow FC, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T: Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care 40:630-639, 2002 

  11. 10.1176/appi.ps.52.6.805 Svarstad BL, Shireman TI, Sweeney JK: Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv 52:805-811, 2001 

  12. 10.1093/ajhp/52.14_Suppl_3.S27 Cramer JA: Relationship between medication adherence and medical outcomes. Am J Health Syst Pharm 52:527-529, 1995 

  13. 10.1007/BF01858007 Hays RD, Kravitz RL, Mazel RM, Sherbourne CD, DiMatteo MR, Rogers WH, Greenfield S: The impact of patient adherence on health outcomes for patients with chronic disease in the Medical Outcomes Study. J Behav Med 17:347-360, 1994 

  14. 10.1016/S0149-2918(03)80347-8 Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT: Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 25:2958-2971, 2003 

  15. 10.1097/00005650-199909000-00002 Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, Canning C, Platt R: Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to anti-hypertensive therapy. Med Care 37:846-857, 1999 

  16. 10.1016/S0149-2918(99)80026-5 Farmer KC: Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21:1074-1090, 1999 

  17. 10.1520/JFS14375J Duncan JC, Rogers R: Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders. J Forensic Sci 43:1133-1137, 1998 

  18. 10.2337/diacare.23.1.23 Gary TL, Crum RM, Cooper-Patrick L, Ford D, Brancati FL: Depressive symptoms and metabolic control in African Americans with type 2 diabetes. Diabetes Care 23:23-29, 2000 

  19. 10.1111/j.1365-2710.1993.tb00591.x Skaer TL, Sclar DA, Markowski DJ, Won JK: Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures: a study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther 18:295-299, 1993 

  20. 10.1016/0021-9681(87)90171-8 Charlson ME, Pompei P, Ales KL, McKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373-383, 1987 

  21. 10.1016/0895-4356(93)90103-8 Romano PS, Roos LL, Jollis JG: Adapting a clinical comorbidity index for use with ICD-9-CM administrative data. J Clin Epidemiol 46:1075-1079, 1993 

  22. 10.1016/0895-4356(93)90106-B Romano PS, Roos LL, Jollis JG: Furthering evidence concerning the use of a clinical comorbidity index with ICD-9-CM administrative data. J Clin Epidemiol 46:1085-1090, 1993 

  23. Diggle PJ, Liang KY, Zeger S: Transition models. In Analysis of Longitudinal Data. New York, Oxford University Press, 1999, p. 45-62 

  24. Chousa FP, Guillen VFG, Otero MD, Beltran DO, Lopez RP, Sanchez JM: Usefulness of six indirect methods to evaluate drug therapy compliance in non-insulin-dependent diabetes mellitus. Revista Clinica Espanola 197:555-559, 1997 

  25. 10.1097/00007611-198703000-00014 Diehl AK, Bauer RL, Sugarek NJ: Correlates of medication compliance in non-insulin-dependent diabetes mellitus. South Med J 80:332-335, 1987 

  26. 10.1111/j.1445-5994.1984.tb04276.x Peterson GM, McLean S, Senator GB: Determinants of patient compliance, control, presence of complications, and handicap in non-insulin-dependent diabetes. Aust N Z J Med 14:135-141, 1984 

  27. 10.1001/jama.285.2.182 Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC: Effect of improved glycemic control on health care costs and utilization. JAMA 285:182-189, 2001 

  28. 10.1097/00005650-198808000-00007 Steiner JF, Koepsell TD, Fihn SD, Inui TS: A general method of compliance assessment using centralized pharmacy records: description and validation. Med Care 26:814-823, 1988 

  29. Rudd P. The measurement of compliance: medication taking. In Developmental Aspects of Health Compliance Behavior. Krasnegor NA, Epstein L, Johnson SF, Yaffe SJ, Eds. Hillsdale, NJ, Lawrence Erlbaum Associates, 1993, p. 185-213 

  30. 10.1056/NEJM199807233390404 Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998 

  31. 10.1136/bmj.321.7258.405 Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): progressive observational study. BMJ 321:405-412, 2000 

  32. 10.1001/archinte.157.2.181 Abraira C, Colwell J, Nuttall F, Sawin CT, Henderson W, Comstock JP, Emanuele NV, Levin SR, Pacold I, Lee HS: Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial: Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med 157:181-188, 1997 

  33. 10.2337/diacare.24.1.51 Menzin J, Langley-Hawthorne C, Friedman M, Boulanger L, Cavanaugh R: Potential short-term economic benefits of improved glycemic control. Diabetes Care 24:51-55, 2001 

관련 콘텐츠

원문 보기

원문 URL 링크

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로